Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPHA | NGEN | MENS | ||
| Company | Innate Pharma S.A. ADR | Nervgen Pharma Corp | Jyong Biotech Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.8089 | 2.11 | 2.17 | ||
| High | 1.8772 | 2.22 | 2.38 | ||
| Low | 1.8000 | 2.09 | 2.08 | ||
| Latest | 1.8000 | 2.12 | 2.22 | ||
| Change | -0.0100 | +0.03 | +0.17 | ||
| % Change | -0.55% | +1.44% | +8.29% | ||
| Volume | 5,900 | 605,200 | 207,400 | ||
| 20-Day Average Volume | 35,555 | 863,125 | 166,655 | ||
| Previous Close | 1.8100 | 2.09 | 2.05 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.7940 | 1.97 | 1.83 | ||
| 20-Day Raw Stochastic | 36.38% | 65.12% | 79.99% | ||
| 20-Day Relative Strength | 52.14 | 41.57 | 56.58 | ||
| Weighted Alpha | -18.09 | -23.36 | -43.67 | ||
| Today's Opinion | 72% Buy | 88% Sell | 40% Sell | ||
| Previous Opinion | 72% Buy | 88% Sell | 64% Sell | ||
| Last Month's Opinion | 24% Buy | 72% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.56% since 06/25/26 | +10.99% since 06/25/26 | +16.84% since 06/25/26 | ||
| Low | 1.7566 on 06/26/26 | 1.85 on 06/26/26 | 1.82 on 06/26/26 | ||
| High | 1.9200 on 06/29/26 | 2.22 on 07/02/26 | 2.40 on 06/30/26 | ||
| 1-Month | |||||
| %Chg | -1.10% since 06/02/26 | +6.00% since 06/02/26 | +2.78% since 06/02/26 | ||
| Low | 1.7100 on 06/05/26 | 1.70 on 06/10/26 | 1.50 on 06/16/26 | ||
| High | 1.9574 on 06/23/26 | 2.35 on 06/22/26 | 2.40 on 06/30/26 | ||
| 3-Month | |||||
| %Chg | +31.39% since 04/02/26 | -50.23% since 04/02/26 | -9.39% since 04/02/26 | ||
| Low | 1.3200 on 05/13/26 | 1.70 on 06/10/26 | 1.50 on 06/16/26 | ||
| High | 2.6199 on 05/14/26 | 4.67 on 04/07/26 | 3.00 on 04/14/26 | ||
| 6-Month | |||||
| %Chg | -1.10% since 01/02/26 | -63.95% since 01/02/26 | -34.90% since 01/02/26 | ||
| Low | 1.1700 on 03/20/26 | 1.70 on 06/10/26 | 1.43 on 02/11/26 | ||
| High | 2.6199 on 05/14/26 | 6.30 on 01/08/26 | 4.30 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 169,060 | 170,938 | 168,782 | ||
| Shares Outstanding, K | 93,922 | 80,631 | 76,028 | ||
| Annual Sales | 10,190,000 | 0 | 0 | ||
| Annual Net Income | -55,640,000 | -31,570,000 | -4,670,000 | ||
| Last Quarter Sales | N/A | 0 | N/A | ||
| Last Quarter Net Income | N/A | -1,220,000 | N/A | ||
| 60-Month Beta | 0.32 | N/A | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.09 on 05/15/26 | N/A | ||
| Earnings Date | 05/13/26 | 08/21/26 | 08/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||